5 new weight-loss drugs to watch in fight for next Ozempic

New FDA Warning Added to Popular Weight Loss Drugs
Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration during general anesthesia or deep sedation. The affected drugs are liraglutide (Saxenda, Victoza), semaglutide (Ozempic, Rybelsus, Wegovy), and tirzepatide (Mounjaro, Zepbound).
5 new weight-loss drugs to watch in the fight for the next Ozempic
Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out drugs are emerging.
Anti-obesity drugs, lifestyle interventions show cardiovascular benefits beyond weight loss
Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to several new papers published in JACC that are being simultaneously presented at the American Heart Association's 2024 Scientific Sessions.
Weight-loss drugs replacing some surgeries, but doctors say they're 'not a miracle drug'
Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, rates of bariatric surgeries dropped by 25%, while prescriptions for weight-loss drugs more than doubled.
Weight-loss drug Wegovy launched in China
Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.
How Often Do Doctors Use New Weight-Loss Drugs in Kids?
As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide and semaglutide are the only two GLP-1 drugs FDA-approved to treat obesity in kids ages 12 and up.
Weight loss drugs Ozempic and Wegovy may also curb alcohol addiction, study says
A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at curbing alcohol abuse.
FDA adds new warning to weight loss drugs
The FDA has added a new warning to drugs including Ozempic and Wegovy, cautioning that patients taking the drugs may be at a higher risk of inhaling gastric contents into their lungs while under
Lost and found: Life after Ozempic and other weight-loss drugs was just the start for these four people
Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage chronic conditions such as diabetes and heart disease and others to help them lose weight.
9 Foods That Have the Same Effect as Weight-Loss Drugs
A registered dietitian reveals nine food that work like weight-loss drugs, helping to curb cravings and suppress your appetite.
Dallas Morning News on MSN11d
FDA adds new warning to weight loss drugs including Wegovy
The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...
New Weight Loss Drug Boosts Energy and Reduces Appetite Without Side Effects
Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...
People on MSN11d
Mom Overdosed on Weight Loss Drug She Got on Instagram, Recalls 'Throwing Up Blood': 'Thought I Was Going to Die'
Leigh-Anne Lagden, 26, opened up about being hospitalized after accidentally overdosing on knockoff weight loss injections ...
Yahoo1d
Diabetes and weight loss drugs shown to reduce alcohol-related hospitalizations, study finds
This isn’t the first study to link GLP-1s to reduced alcohol intake, according to Dr. Sue Decotiis, MD, a weight-loss ...